5407192026-04-012026-06-305407192026-06-305407192026-04-015407192026-04-012026-06-30in-capmkt:PolicyholdersAccountOtherIncome1Member5407192026-04-012026-06-30in-capmkt:PolicyholdersAccountOtherIncome2Member5407192026-04-012026-06-30in-capmkt:PolicyholdersAccountOtherIncome3Member5407192026-04-012026-06-30in-capmkt:PolicyholdersAccountOtherIncome4Member5407192026-04-012026-06-30in-capmkt:PolicyholdersAccountOtherIncome5Member5407192026-04-012026-06-30in-capmkt:PolicyholdersAccountOtherIncome6Member5407192026-04-012026-06-30in-capmkt:PolicyholdersAccountOtherIncome7Member5407192026-04-012026-06-30in-capmkt:OtherOperatingExpenses1Member5407192026-04-012026-06-30in-capmkt:OtherOperatingExpenses2Member5407192026-04-012026-06-30in-capmkt:OtherOperatingExpenses3Member5407192026-04-012026-06-30in-capmkt:OtherOperatingExpenses4Member5407192026-04-012026-06-30in-capmkt:OtherOperatingExpenses5Member5407192026-04-012026-06-30in-capmkt:OtherOperatingExpenses6Member5407192026-04-012026-06-30in-capmkt:OtherOperatingExpenses7Member5407192026-04-012026-06-30in-capmkt:OtherOperatingExpenses8Member5407192026-04-012026-06-30in-capmkt:OtherOperatingExpenses9Member5407192026-04-012026-06-30in-capmkt:OtherOperatingExpenses10Member5407192026-04-012026-06-30in-capmkt:ShareholdersAccountOtherIncome1Member5407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember15407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember25407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember35407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember45407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember55407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember65407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember75407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember85407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember95407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember105407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember115407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember125407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember215407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember225407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember15407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember25407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember35407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember45407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember55407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember65407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember75407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember85407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember95407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember105407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember115407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember125407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember215407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember225407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember15407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember25407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember35407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember45407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember55407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember65407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember75407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember85407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember95407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember105407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember115407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember125407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember215407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember225407192026-06-30in-capmkt:ReportableSegmentsMember15407192026-06-30in-capmkt:ReportableSegmentsMember25407192026-06-30in-capmkt:ReportableSegmentsMember35407192026-06-30in-capmkt:ReportableSegmentsMember45407192026-06-30in-capmkt:ReportableSegmentsMember55407192026-06-30in-capmkt:ReportableSegmentsMember65407192026-06-30in-capmkt:ReportableSegmentsMember75407192026-06-30in-capmkt:ReportableSegmentsMember85407192026-06-30in-capmkt:ReportableSegmentsMember95407192026-06-30in-capmkt:ReportableSegmentsMember105407192026-06-30in-capmkt:ReportableSegmentsMember115407192026-06-30in-capmkt:ReportableSegmentsMember125407192026-06-30in-capmkt:ReportableSegmentsMember215407192026-06-30in-capmkt:ReportableSegmentsMember225407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember15407192026-06-30in-capmkt:ReportableSegmentsMember15407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember25407192026-06-30in-capmkt:ReportableSegmentsMember25407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember35407192026-06-30in-capmkt:ReportableSegmentsMember35407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember45407192026-06-30in-capmkt:ReportableSegmentsMember45407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember55407192026-06-30in-capmkt:ReportableSegmentsMember55407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember65407192026-06-30in-capmkt:ReportableSegmentsMember65407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember75407192026-06-30in-capmkt:ReportableSegmentsMember75407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember85407192026-06-30in-capmkt:ReportableSegmentsMember85407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember95407192026-06-30in-capmkt:ReportableSegmentsMember95407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember105407192026-06-30in-capmkt:ReportableSegmentsMember105407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember115407192026-06-30in-capmkt:ReportableSegmentsMember115407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember125407192026-06-30in-capmkt:ReportableSegmentsMember125407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember215407192026-06-30in-capmkt:ReportableSegmentsMember215407192026-04-012026-06-30in-capmkt:ReportableSegmentsMember225407192026-06-30in-capmkt:ReportableSegmentsMember225407192026-04-012026-06-30

AuditorDomain1

5407192026-04-012026-06-30

AuditorDomain2

iso4217:INRxbrli:pureiso4217:INRxbrli:shares

540719

SBILIFE

NOTLISTED

INE123W01016

SBI LIFE INSURANCE COMPANY LIMITED

Main Board

Equity

Non-Linked Policy And Linked Policy

2026-04-01

2027-03-31

2026-07-24

2026-07-10

INR

Lakhs

Quarterly

First quarter

2026-07-24

11:00:00

2026-07-24

14:35:00

Declaration of unmodified opinion

false

The Company doesn't have any borrowings hence the disclosure with respect to defualt on loans and borrowing is not applicable

2026-04-01

2026-06-30

Unaudited

Standalone

49549341000

123817864000

39529347000

212896552000

200782091000

259770211000

354653000

460906955000

6123604000

2515075000

656917000

9295596000

7986254000

543468000

7824836000

16354558000

25650154000

952000

-2639000

3964000

472547000

131267243000

298115630000

455507851000

5399104000

4577844000

821260000

67543000

5399104000

1275724000

6742371000

4577844000

2815500000

1920000

2817420000

7395264000

69440000

-132922000

-63482000

7458746000

209415000

7249331000

185549922000

10032405000

188220124000

2940102000

184775869000

2221973848000

2834794189000

5241543906000

18916857000

5260460763000

1.96

0.1205

251441000

7.23

7.22

0.0719

0.072

0.0548

0.2335

0.2116

0.3407

674000

2222000

0.8435

0.7675

0.7091

0.679

0.591

0.879

1. The Company doesn't have any subsidiary/associate/joint venture companies requiring consolidation under AS-21; therefore consolidated financial statements are not applicable to the Company. 2. The above financial results for the quarter ended June 30, 2026 have been reviewed by the Board Audit Committee and approved by the Board of Directors at its meeting held on July 23, 2026 and July 24, 2026 respectively. 3. The financial results have been prepared in accordance with the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended and IRDA circular IRDA/F&I/REG/CIR/208/10/2016 dated October 25, 2016 on publication of financial results for life insurance companies. 4. The above financial results have been reviewed by the Joint Statutory Auditors, M/s. K S Aiyar & Co, Chartered Accountants and M/s J Singh & Associates, Chartered Accountants. 5. In view of seasonality of the industry, the financial results for the quarter or interim period are not necessarily indicative of the results that may be expected of any other interim period or full year. 6. During the quarter ended June 30, 2026 the Company has allotted 148,413 equity shares with face value of Rs.10 each to its eligible employees pursuant to exercise of employee stock options in accordance with the Company's Employee Stock Option Scheme 2018 ("ESOS 2018"). 7. Insurance Regulatory and Development Authority of India (‘IRDAI’) vide its order dated June 2, 2023 (‘IRDAI order’) passed in terms of section 52B (2) of the Insurance Act, 1938 has directed to transfer the life insurance business of Sahara India Life Insurance Company Limited (‘SILIC’) involving policy liabilities and policyholders’ investment/ assets to SBI Life Insurance Company Limited (‘SBI Life’ or ‘the Company’). On appeal filed by SILIC against the said IRDAI order, the Securities Appellate Tribunal ('SAT' or 'Tribunal') vide its order dated June 13, 2023 has granted stay on the effect and operation of the said IRDAI order. Subsequently, the IRDAI has filed an appeal with Hon’ble Supreme Court against the stay order passed by SAT. The Hon’ble Supreme Court in its hearing held on July 17, 2023 has set aside Securities Appellate Tribunal’s (SAT) stay and directed the SAT to hear the case and decide it afresh. Thereafter, the SAT, vide its order dated December 5, 2025, has dismissed the appeal filed by SILIC and upheld the order passed by the IRDAI dated June 2, 2023 therefore the order is no longer sub judice. The Company had sought necessary directions from IRDAI for compliance with the IRDAI Order dated June 2, 2023. As per the Authority’s directions, the Company shall continue to maintain separate books of account for SILIC during FY 2026-27. Accordingly, the closing balance of SILIC portfolio as at March 31, 2027 and transactions from April 1, 2027, pertaining to SILIC’s Policyholder’s shall be reflected in the Company’s financial statements. 8. IRDAI has issued the IRDAI (Actuarial, Finance and Investment Functions of Insurers) (Amendment) Regulations, 2026 (“Amended Regulations”), mandating that all insurance companies prepare their financial statements in accordance with the applicable Indian Accounting Standards (Ind AS) with effect from April 1, 2026. The Amended Regulations also provide insurers the option to seek a one year forbearance, subject to prior approval of IRDAI, for deferring the implementation of Ind AS. In accordance with the above regulatory provisions and the Board approved Ind AS transition plan, the Company submitted an application to IRDAI seeking a one year forbearance. IRDAI has granted the forbearance for FY 2026-27, permitting the Company to defer the adoption of Ind AS by one year. Accordingly, these financial results of the Company are prepared in accordance with Indian GAAP (accounting principles generally accepted in India). 9. In accordance with requirement of IRDAI Master Circular on 'Presentation of Financial Statements and Filing of Returns' and IRDAI circular no. IRDAI/F&A/CIR/MISC/256/09/2021 dated September 30, 2021, the Company will publish the financials on the Company's website latest by August 14, 2026. 10. Analytical ratios have been calculated as per definition given in IRDAI Analytical ratios disclosures. 11. Basic and diluted EPS is not annualized for three months. 12. The persistency ratios are calculated as per IRDAI circular IRDAI/NL/MSTCIR/RT/93/6/2024 dated June 14, 2024. i) Persistency ratios for the three months ended June 30, 2026 are "for the quarter" persistency calculated using policies issued in 1st March to 31st May of the relevant years. 13. Net Premium is Net of reinsurance 14. Income from investments is net of amortisation and Losses (including capital gains) 15. Profit and Loss carried forward to balance sheet represents accumulated profit. 16.Net Commission includes rewards. 17. The figures of quarter ended March 31, 2026 as reported in these financial results are the balancing figures between audited figures in respect of full financial year and published year-to-date figures upto the end of the third quarter of the relevant financial year. 18. Figures of the previous period/year have been regrouped/ reclassified/restated wherever necessary, in order to make them comparable.

Unclaim Investment Income

3761000

Bank Charges recovery

292000

Interest on renewal Premium

681000

Interest on revived policies

99486000

Stale Cheque written back

99000

FMC Income on Variable insurance products (VIP)

Other Income

250334000

Legal & professional charges

748953000

Depreciation

346616000

Rent, rates & taxes

388883000

Information technology expenses

673560000

Stamp duty on policies

1534689000

Travel, conveyance and vehicle running expenses

361830000

Repairs

17288000

Communication expenses

211261000

Training Expenses

74541000

Other expenses

3467215000

Profit/(Loss )on sale of Fixed Asset

1920000

Participating Life

13474298000

10708042000

33636000

Participating Pension

410074000

649142000

925000

Participating VIP

16764000

96814000

-9000

Non Participating Life

39720818000

13956636000

312311000

Non Participating Pension

10189000

58372000

7000

Non Participating Group Life

35152238000

7921264000

536000

Non Participating Annuity

14858334000

5944001000

966000

Non Participating Health

28581000

50043000

56000

Non Participating VIP

21645000

256655000

25000

Linked Individual Life

77522998000

184696977000

24523000

Linked Group

2458600000

901778000

-34000

Linked Pension

17107552000

34533126000

-18318000

Shareholders

2948443000

1920000

Unallocated

Participating Life

686346000

Participating Pension

110172000

Participating VIP

85116000

Non Participating Life

-2140116000

Non Participating Pension

29936000

Non Participating Group Life

2559323000

Non Participating Annuity

31875000

Non Participating Health

51685000

Non Participating VIP

111915000

Linked Individual Life

2132079000

Linked Group

-16211000

Linked Pension

1756963000

Shareholders

2671488000

Unallocated

1. Segments include: a. Linked Policies: (i) Life (ii) General Annuity and Pension (iii) Health (iv) Variable b. Non-Linked 1. Non-Participating Policies: (i) Life (ii) General Annuity and Pension (iii) Health (iv) Variable 2. Participating Policies : (i) Life (ii) General Annuity and Pension (iii) Health (iv) Variable c. Variable insurance further segregated into Life, General Annuity and Pension and Health where any such segment contributes ten per cent or more of the total premium of the Company. 2. Net of Provisions for diminution in value of investments and provision for standard and non-standard assets. 3. Segment policy liabilities includes fund for future appropriation and Credit/(debit) fair value change account on policyholders fund.

Participating Life

627245209000

Participating Pension

35533354000

Participating VIP

3450253000

Non Participating Life

735084294000

Non Participating Pension

2655765000

Non Participating Group Life

446688254000

Non Participating Annuity

345460340000

Non Participating Health

1449725000

Non Participating VIP

9375929000

Linked Individual Life

2175389947000

Linked Group

20114118000

Linked Pension

658267320000

Shareholders

201209841000

Unallocated

-1463607000

Participating Life

626865806000

Participating Pension

35168723000

Participating VIP

3412252000

Non Participating Life

735768505000

Non Participating Pension

2566177000

Non Participating Group Life

446376218000

Non Participating Annuity

345384743000

Non Participating Health

1419800000

Non Participating VIP

8928276000

Linked Individual Life

2174997206000

Linked Group

20137340000

Linked Pension

658225855000

Shareholders

201209841000

Unallocated

Unaudited

true

M/s K S Aiyar & Co

true

2028-05-31

M/s J Singh & Associates

true

2028-12-31